What Does Scribe Therapeutics Do?

Total employees230
HeadquartersAlameda
Founded2018

Scribe Therapeutics is a molecular engineering company focused on creating a new era of CRISPR-based genetic medicines. By pioneering its 'CRISPR by Design™' platform, Scribe aims to develop therapies that are safer, more effective, and can be delivered to a broader range of tissues and cell types. The company is dedicated to engineering custom X-Editing (XE) molecules for in vivo applications, tackling diseases with significant unmet medical needs and striving to move the entire field of genetic medicine forward.

Where Is Scribe Therapeutics's Headquarters?

Scribe Therapeutics officeScribe Therapeutics officeScribe Therapeutics officeScribe Therapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

Primary hub for research and development of CRISPR-based genetic medicines, molecular engineering, corporate operations, and strategic partnerships.

Notable Features:

State-of-the-art laboratory and office space spanning approximately 132,000 square feet, custom-designed to support advanced molecular engineering, therapeutic development, and collaborative research.

Work Culture:

Scribe Therapeutics fosters a dynamic, science-driven, and innovative work environment. The culture emphasizes collaboration, rigorous scientific inquiry, and a shared mission to develop transformative therapies for patients. Employees are encouraged to be pioneers in their respective fields.

HQ Significance:

The Alameda headquarters represents a significant investment in Scribe's growth, enabling the company to scale its research, development, and operational capabilities. It centralizes its talent and technology to accelerate the advancement of its CRISPR gene editing pipeline.

Values Reflected in HQ: The state-of-the-art facility underscores Scribe's commitment to cutting-edge science, innovation, and excellence. Its location in the San Francisco Bay Area biotech cluster reflects its drive to be at the forefront of genetic medicine.

Location:

While Scribe Therapeutics is headquartered and primarily operates from California, USA, it establishes a global presence through strategic collaborations with major pharmaceutical companies like Sanofi and Biogen. These partnerships aim to leverage Scribe's CRISPR technologies for the development and potential commercialization of therapies worldwide, addressing global unmet medical needs.

Street Address:

600 West Tower Ave

City:

Alameda

State/Province:

CA

Country:

USA

Where Else Does Scribe Therapeutics Operate Around the World?

N/A

Address: N/A

The company's strategy appears focused on consolidating its core operations at its expansive Alameda campus to foster collaboration and efficiency.

Buying Intent Signals for Scribe Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Scribe Therapeutics? Meet the Executive Team

As of April 2025, Scribe Therapeutics' leadership includes:

Benjamin L. Oakes, Ph.D. - Co-Founder, President & Chief Executive Officer
Brett E. Staahl, Ph.D. - Co-Founder & Chief Scientific Officer
Svetlana Lucas, Ph.D. - Chief Business Officer
Sunny Chim, CPA - Chief Financial Officer
David K. Stone, J.D. - General Counsel
Shilpa Shroff, Ph.D. - Chief People Officer

Who's Investing in Scribe Therapeutics?

Scribe Therapeutics has been backed by several prominent investors over the years, including:

Andreessen Horowitz (a16z)
Avoro Ventures
OrbiMed
Perceptive Advisors
Redmile Group
Wellington Management
RA Capital Management
Menlo Ventures
Google Ventures (GV)
Cowen Healthcare Investments
Omega Funds
TCG Crossover
Surveyor Capital (a Citadel company)
Pura Vida Investments
funds and accounts managed by T. Rowe Price Associates, Inc.

What Leadership Changes Has Scribe Therapeutics Seen Recently?

Hire4
Exits0

Scribe Therapeutics significantly bolstered its leadership team over the past year with four key C-suite appointments, enhancing its capabilities in business development, finance, legal affairs, and human resources to support its continued growth and pipeline advancement. No prominent executive departures were publicly announced during this period.

New Appointments:

Svetlana Lucas, Ph.D., Svetlana Lucas, Ph.D., appointed as Chief Business Officer to lead Scribe's business development, corporate strategy, and alliance management efforts.
Sunny Chim, CPA, Sunny Chim, CPA, joined as Chief Financial Officer, bringing extensive experience to oversee the company's financial strategy and operations.
Shilpa Shroff, Ph.D., Shilpa Shroff, Ph.D., appointed as Chief People Officer to spearhead talent acquisition, development, and culture initiatives.
David K. Stone, J.D., David K. Stone, J.D., joined as General Counsel, responsible for leading the company's legal and compliance functions.

What Technology (Tech Stack) Is Used byScribe Therapeutics?

Discover the tools Scribe Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Scribe Therapeutics Email Formats and Examples

Scribe Therapeutics likely uses common corporate email formats. Based on industry patterns and available data, the most probable format is [first_initial][last]@scribetx.com or [first].[last]@scribetx.com.

[first_initial][last]@scribetx.com

Format

boakes@scribetx.com

Example

75%

Success rate

What's the Latest News About Scribe Therapeutics?

Scribe Therapeutics Press Release • January 4, 2024

Scribe Therapeutics Announces Expansion of Strategic Collaboration with Sanofi to Create In Vivo Medicines Using Scribe’s CRISPR X-Editing Technologies

Scribe Therapeutics and Sanofi expanded their existing collaboration to include a new project leveraging Scribe’s X-Editing (XE) technologies for developing in vivo therapies. Scribe received an upfront payment and is eligible for future milestone payments and royalties....more

Scribe Therapeutics Press Release • December 5, 2023

Scribe Therapeutics Appoints Sunny Chim, CPA, as Chief Financial Officer

Scribe Therapeutics announced the appointment of Sunny Chim as its new Chief Financial Officer. Mr. Chim brings over 20 years of financial leadership experience in the biopharmaceutical industry to Scribe....more

Scribe Therapeutics Press Release • October 3, 2023

Scribe Therapeutics Appoints Svetlana Lucas, Ph.D., as Chief Business Officer

Scribe Therapeutics appointed Svetlana Lucas, Ph.D., as Chief Business Officer. Dr. Lucas will lead the company's business development, corporate strategy, and alliance management functions....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Scribe Therapeutics, are just a search away.